Status:
RECRUITING
Textbook Outcomes of Right Hemihepatectomy in Patients With Hepatocellular Carcinoma
Lead Sponsor:
West China Hospital
Conditions:
Hepatocellular Carcinoma
Hepatectomy
Eligibility:
All Genders
18+ years
Brief Summary
Although traditional open right hemihepatectomy is a mature technique, the incision is usually very large; Intraoperative bleeding may be excessive, and postoperative liver failure is also prone to oc...
Eligibility Criteria
Inclusion
- Age ≥ 18 years old;
- The lesion is limited to the right half of the liver and diagnosed as hepatocellular carcinoma based on paraffin pathology and immunohistochemistry results;
- The type of surgery is elective surgery;
- The patient's preoperative liver function was Child Pugh A or B grade, and the preoperative ASA (American Society of Anesthesiologists) rating was I, II, or III.
Exclusion
- Pathological confirmed cholangiocarcinoma, mixed cell carcinoma, or extrahepatic metastatic malignant tumors;
- Previous history of upper abdominal surgery;
- Simultaneously undergoing adjacent abdominal organ resection, major vessel and biliary reconstruction surgery, except for the gallbladder;
- Merge adjacent organ invasions except for the gallbladder, with main blood vessels, bile duct cancer emboli, or distant metastases;
- Lost to follow-up or loss of primary clinical data.
Key Trial Info
Start Date :
April 5 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 15 2025
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT06950827
Start Date
April 5 2025
End Date
May 15 2025
Last Update
April 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
West China Hospital
Chengdu, Sichuan, China, 610041